Bayer applies to sell kidney cancer drug in Europe
12th Sep 2005, 20:22 GMT
Bayer Pharmaceuticals Corp. has submitted a marketing application with European regulators to sell an experimental kidney cancer drug it has co-developed with Onyx Pharmaceuticals Inc., the companies announced Monday.
Latest news from bizjournals.com Health Care:Pharmaceuticals headlines:
- United BioSource makes 10th buy, looks for more
- Nonprofits starting to invest in drug companies
- Accentia making changes to its business formula, market focus
- GSK terminates agreement for Genaera frog product
- Gladstone and Merck team to bring drugs to market
- Abbott expects to double vascular business sales
- Mayo to shut down drug-testing unit
- MIT, Dana-Farber win major cancer grants
- Service Bancorp chair resigns
- Introgen strikes nanotech deal with M.D. Anderson